Review Article Published: December 2002 Fundamentals of experimental design for cDNA microarrays Gary A. Churchill Nature Genetics 32, 490–495 (2002) Cite this article ...

SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a ...

One of the current – and dominant – factors is compliance with data sovereignty laws. Regulations such as the UK GDPR and the ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

Companies are looking beyond the experimental phase of AI and exploring ways to productize and scale agents and other applications.

Rapid stabilization and regression of atherosclerosis, even for advanced complex plaques, has been achieved experimentally in both animals and humans. In this insightful Review, Kevin Williams ...

Scientists show that the frequency of a set of words seems to have increased in published study abstracts since ChatGPT was ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

This article explores the current applications of artificial intelligence (AI) in chromatography. It anticipates AI’s ...

Why use expensive AI inferencing services in the cloud when you can use a small language model in your web browser?

Gartner’s research indicates that many agentic AI initiatives are still in early experimental phases, often fueled more by hype than by strategic planning.